Călin D. Popa

4.5k citations
59 papers · 3.5k · 2 hit papers · h-index 27

Impact in

  • Rheumatology top 0.5%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Immunology top 2%
    • Immune responses and vaccinations
    • Immune Response and Inflammation
    • Immune cells in cancer

Papers in

  • Rheumatology 30
    • Rheumatoid Arthritis Research and Therapies 21
    • Systemic Lupus Erythematosus Research 6
    • Osteoarthritis Treatment and Mechanisms 4
  • Immunology 12
    • Immune Response and Inflammation 5
    • Atherosclerosis and Cardiovascular Diseases 3
Co-authors
Mihai G. Netea (14 shared papers)Piet L. C. M. van Riel (16 shared papers)J.W.M. van der Meer (9 shared papers)Anton F. H. Stalenhoef (7 shared papers)Jaap Fransen (13 shared papers)Elke Arts (10 shared papers)Leo A. B. Joosten (13 shared papers)Alfons A den Broeder (13 shared papers)
Journals
Annals of the Rheumatic Diseases (17 papers)Cytokine (3 papers)Lara D. Veeken (2 papers)Nature Reviews Rheumatology (2 papers)Scientific Reports (2 papers)
Partner nations
NetherlandsUnited StatesItaly

In The Last Decade

Călin D. Popa

54 papers receiving 3.4k citations

Călin D. Popa's Hit Papers

Metabolic Induction of Trained Immunity through the Mevalonate Pathway 2018 · 555 citations
5550+6+12Years since publication200400600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2018 Cell
  2. 2007 Journal of Lipid Research

Peers

Călin D. Popa
Comparison fields: 5 of 114
  • Rheumatology 1.2k
  • Immunology 1.1k
  • Endocrine and Autonomic Systems 82
  • Cardiology and Cardiovascular Medicine 249
  • Hematology 129
Replace José Francisco Muñóz-Valle with:
José Francisco Muñóz-Valle Mexico
Xiaofeng Li China
Deh‐Ming Chang Taiwan
Yoshikazu Kinoshita Japan
Koichiro Asano Japan
Rasheed Ahmad Kuwait
Peter J. Jose United Kingdom
Isela Parra‐Rojas Mexico
Huang‐Yu Yang Taiwan
Pierpaolo Sileri Italy
Călin D. Popa relative to José Francisco Muñóz-Valle Mexico José Francisco Muñóz-Valle's profile →
Citations per field
00.5×1.7×
José Francisco Muñóz-Valle · 1×
Citations per year

Countries citing papers authored by Călin D. Popa

Since Specialization
Citations

This map shows the geographic impact of Călin D. Popa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Călin D. Popa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Călin D. Popa more than expected).

Fields of papers citing papers by Călin D. Popa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Călin D. Popa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Călin D. Popa. The network helps show where Călin D. Popa may publish in the future.

Co-authors

The 25 scholars most cited alongside Călin D. Popa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Călin D. Popa Line = papers co-authored together Călin D. Popa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk
Journal of Lipid Research ·Călin D. Popa, Mihai G. Netea, Piet L. C. M. van Riel, J.W.M. van der Meer, Anton F. H. Stalenhoef
Hit paper breakdown →		2007622
2
Metabolic Induction of Trained Immunity through the Mevalonate Pathway
Cell ·Siroon Bekkering, Rob J.W. Arts, Boris Novakovic, Ioannis Kourtzelis, Charlotte D.C.C. van der Heijden, Yang Li, Călin D. Popa, Rob ter Horst, Julia van Tuijl, Romana T. Netea‐Maier, Frank L. van de Veerdonk, Triantafyllos Chavakis, Leo A. B. Joosten, J.W.M. van der Meer, Henk G. Stunnenberg, Niels P. Riksen, Mihai G. Netea
Hit paper breakdown →		2018555
3
Inhibition of toll‐like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis
Arthritis & Rheumatism ·Shahla Abdollahi‐Roodsaz, Leo A. B. Joosten, Mieke F. Roelofs, Timothy R. D. J. Radstake, Giovanni Matera, Călin D. Popa, J.W.M. van der Meer, Mihai G. Netea, Wim B. van den Berg
2007269
4
Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis
Annals of the Rheumatic Diseases ·Elke Arts, Călin D. Popa, Alfons A den Broeder, Anne Grete Semb, Tracey E. Toms, George D. Kitas, P.L. van Riel, Jaap Fransen
2014214
5
Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
Annals of the Rheumatic Diseases ·Călin D. Popa, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)
2004190
6
Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis
Annals of the Rheumatic Diseases ·Călin D. Popa, (unknown), (unknown), (unknown), (unknown), (unknown)
2005143
7
Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis
Annals of the Rheumatic Diseases ·Călin D. Popa, F.H.J. van den Hoogen, Timothy R. D. J. Radstake, Mihai G. Netea, Agnes Eijsbouts, Martin den Heijer, J.W.M. van der Meer, Piet L. C. M. van Riel, Anton F. H. Stalenhoef, Pilar Barrera
2007131
8
The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients
Annals of the Rheumatic Diseases ·Elke Arts, Jaap Fransen, Alfons A den Broeder, Călin D. Popa, Piet L. C. M. van Riel
2014117
9
Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients
Annals of the Rheumatic Diseases ·Călin D. Popa, Lambertus J.H. van Tits, Pilar Barrera, Heidi Lemmers, F.H.J. van den Hoogen, Piet L. C. M. van Riel, Timothy R. D. J. Radstake, Mihai G. Netea, Manon van Roest, Anton F. H. Stalenhoef
2008105
10
Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms
Annals of the Rheumatic Diseases ·Elke Arts, Călin D. Popa, Alfons A den Broeder, Rogier Donders, Aamer Sandoo, Tracey E. Toms, Silvia Rollefstad, Eirik Ikdahl, Anne Grete Semb, George D. Kitas, Piet L. C. M. van Riel, Jaap Fransen
201586
11
Cardiovascular effects of approved drugs for rheumatoid arthritis
Nature Reviews Rheumatology ·Fabiola Atzeni, Javier Rodríguez‐Carrio, Călin D. Popa, Michael T. Nurmohamed, Gabriella Szűcs, Zoltán Szekanecz
202178
12
Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study
Annals of the Rheumatic Diseases ·Elke Arts, Jaap Fransen, Alfons A den Broeder, Piet L. C. M. van Riel, Călin D. Popa
201778
13
Bartonella quintanaLipopolysaccharide Is a Natural Antagonist of Toll-Like Receptor 4
Infection and Immunity ·Călin D. Popa, Shahla Abdollahi‐Roodsaz, Leo A. B. Joosten, Nozomi Takahashi, Tom Sprong, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Marcel van Deuren, Bart Jan Kullberg, Wim B. van den Berg, J.W.M. van der Meer, Mihai G. Netea
200773
14
Circulating Leptin and Adiponectin Concentrations During Tumor Necrosis Factor Blockade in Patients with Active Rheumatoid Arthritis
The Journal of Rheumatology ·Călin D. Popa, Mihai G. Netea, Jacqueline de Graaf, F.H.J. van den Hoogen, Timothy R. D. J. Radstake, Helga Toenhake-Dijkstra, Piet L. C. M. van Riel, J.W.M. van der Meer, Anton F. H. Stalenhoef, Pilar Barrera
200963
15
Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis
Annals of the Rheumatic Diseases ·L. van Bon, Călin D. Popa, Richard Huijbens, Madelon C Vonk, Michael York, Robert W. Simms, Roger Hesselstrand, Dirk M. Wuttge, Robert Lafyatis, Timothy R. D. J. Radstake
201057
16
Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
Mediators of Inflammation ·Călin D. Popa, Elke Arts, Jaap Fransen, Piet L. C. M. van Riel
201255
17
TLR2 Promotes Th2/Th17 Responses via TLR4 and TLR7/8 by Abrogating the Type I IFN Amplification Loop
The Journal of Immunology ·Mark H. Wenink, Kim C. M. Santegoets, J. C. A. Broen, Lenny van Bon, Shahla Abdollahi‐Roodsaz, Călin D. Popa, Richard Huijbens, Thijs Remijn, Erik Lubberts, Piet L. C. M. van Riel, Wim B. van den Berg, Timothy R. D. J. Radstake
200952
18
Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases
Atherosclerosis ·Michelle S. M. A. Damen, Călin D. Popa, Mihai G. Netea, Charles A. Dinarello, Leo A. B. Joosten
201751
19
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial
RMD Open ·Laurette van Boheemen, Samina A. Turk, Marian H. van Beers-Tas, Wouter H Bos, Diane Marsman, E. N. Griep, Mirian Starmans‐Kool, Călin D. Popa, Alper van Sijl, Maarten Boers, Michael T. Nurmohamed, Dirkjan van Schaardenburg
202145
20
Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis
Annals of the Rheumatic Diseases ·B J Radovits, D A Popa-Diaconu, Călin D. Popa, Agnes Eijsbouts, Roland Laan, Piet L. C. M. van Riel, Jaap Fransen
200845

About Călin D. Popa

Călin D. Popa is a scholar working on Rheumatology, Immunology, Oncology, Infectious Diseases and Pathology and Forensic Medicine, having authored 59 papers that have together received 3.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (21 papers), Cytokine Signaling Pathways and Interactions (7 papers), Systemic Lupus Erythematosus Research (6 papers), Immune Response and Inflammation (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers), Vector-borne infectious diseases (3 papers), Pharmacological Effects of Natural Compounds (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). The work is most often cited by research in Rheumatology (1.2k citations), Immunology (1.1k citations), Endocrine and Autonomic Systems (82 citations), Cardiology and Cardiovascular Medicine (249 citations) and Hematology (129 citations). Călin D. Popa has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Mihai G. Netea, Piet L. C. M. van Riel, J.W.M. van der Meer, Anton F. H. Stalenhoef, Jaap Fransen, Elke Arts, Leo A. B. Joosten, Alfons A den Broeder, Timothy R. D. J. Radstake and Wim B. van den Berg. Their work appears in journals such as Annals of the Rheumatic Diseases, Cytokine, Lara D. Veeken, Nature Reviews Rheumatology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Francisco Muñóz-ValleBreakdown of academic impact, for papers by Xiaofeng LiBreakdown of academic impact, for papers by Deh‐Ming ChangBreakdown of academic impact, for papers by Yoshikazu KinoshitaBreakdown of academic impact, for papers by Koichiro AsanoBreakdown of academic impact, for papers by Rasheed AhmadBreakdown of academic impact, for papers by Peter J. JoseBreakdown of academic impact, for papers by Isela Parra‐RojasBreakdown of academic impact, for papers by Huang‐Yu YangBreakdown of academic impact, for papers by Pierpaolo Sileri